HP and Sepsis: However, recent animal studies of haptoglobin supplementation for treatment of increased cell-free hemoglobin in sepsis [22-24] have created new interest in these biomarkers as potential endogenous protectants against morbidity and as well as potential therapeutics in humans with sepsis.